Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 4 recruiting now small index

Acute Hypoxemic Respiratory Failure clinical trials

4 of 6 indexed Acute Hypoxemic Respiratory Failure trials are currently recruiting.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

6 US clinical trials · 4 currently recruiting · #2,866 of 28,707 conditions by registered trial count

Acute Hypoxemic Respiratory Failure: 6 US clinical trials tracked, 4 recruiting.

Acute Hypoxemic Respiratory Failure is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. The most active sponsor is Dr. Negrin University Hospital, running 1 of these trials.

Enrollment posture brief

Registry condition acute-hypoxemic-respiratory-failure

OPEN 4 | RECR 67% | LATE 0 | EARLY 0 | RANK #2866 | SPON 1

Nearest open-share peer: Adenocarcinoma of Lung (67% recruiting · 6 trials)

Acute Hypoxemic Respirat (th…67%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%Acute Renal Failure16.7%
Open-enrollment share among volume-matched conditions near Acute Hypoxemic Respiratory Failure

Acute Hypoxemic Respiratory Failure lists 4 open slots (67% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Acute Hypoxemic Respiratory Failure on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Acute Hypoxemic Respiratory Failure is recruiting above its size-band peers.

    4 of 6 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Acute Hypoxemic Respiratory Failure research.

    Dr. Negrin University Hospital accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.

  3. Typical Acute Hypoxemic Respiratory Failure enrolment sits around 400 participants.

    Median target enrolment is 400 among the 6 trials that report a genuine target (sentinel values excluded). 2 of those (33.3%) plan for fewer than 100 participants.

  4. Acute Hypoxemic Respiratory Failure research is mostly interventional.

    5 interventional and 1 observational studies make up this index (83.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on Acute Hypoxemic Respiratory Failure records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Moderate Intensity Anticoagulation Other
1 trials
Low intensity anticoagulation Other
1 trials
Mechanical ventilation Device
1 trials
Epic notification alert Behavioral
1 trials
ROX index algorithm Diagnostic test
1 trials
Hfnc + Cnep30 Device
1 trials
Hfnc + Cnep20 Device
1 trials
Hfnc + Cnep10 Device
1 trials

US sites by state

Facility locations filed on Acute Hypoxemic Respiratory Failure trials. A trial with sites in several states counts in each.

New York 2 trials
Illinois 2 trials
Texas 1 trials
Tennessee 1 trials
Colorado 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Acute Hypoxemic Respiratory Failure page

6 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Acute Hypoxemic Respiratory Failure condition card totals 6 registered trials; most-linked intervention Moderate Intensity Anticoagulation; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.